Reply to Letter to the editor: efficacy and safety of a combination of HER2-targeted agents as first-line treatment for metastatic HER2-positive breast cancer: a network meta-analysis.

Expert Opin Drug Saf

b Department of Pharmacy , An-Nan Hospital, China Medical University, Tainan , Taiwan.

Published: December 2018

Download full-text PDF	Source
http://dx.doi.org/10.1080/14740338.2018.1545380	DOI Listing

Publication Analysis

reply letter

letter editor

editor efficacy

efficacy safety

safety combination

combination her2-targeted

her2-targeted agents

agents first-line

first-line treatment

treatment metastatic

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!